Determination of MDA as oxidative stress marker and most common type of blood group in asthmatic patients before and after treatment with montelukast drug.
Article Sidebar
Main Article Content
Abstract
Asthma is a complex chronic inflammatory disorder of airways characterized by airway smooth muscle hypertrophy, hyperplasia and over production of mucous in which many cells and cellular elements play an important role.
The aim of the study is to monitor the changes in asthmatic patients before and after treatment with montelukast in the MDA level as oxidative stress marker in asthmatic cases, and the most common type of blood group. The total number of subjects included in this study was two hundred with acute asthma. The major part of this study represents a follow up study.
Subjects with bronchial asthma were previously diagnosed but not on regular treatment, their aged ranged between (16 – 50) years attending the respiratory unit directly at tikrit teaching hospital. The period of data collection was from first of April of 2013 up to the mid of June- 2014.
There is a significant change in level of MDA, during the asthmatic attacks (1.12± 0.42, while after treatment (0.6 ± 0.34 P ≤ 0.001). The most common type of blood group in asthmatic cases is type O which about 69% from total number of cases , type A about 18.5%, type B about 9% , and type AB about 3.5%).
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Von Mutius, E; Drazen, JM. "A patient with asthma seeks medical advice in 1828, 1928, and 2012". New England Journal of Medicine.2012; 366 (9): 827-34
2- Opolski M, Wilson. Asthma and depression: pragmatic review of the Literature and recommendations for future research". Clin Pract Epidemol Ment Health.2005; 1:18
3- Martinez FD. "Genes, environments, development and asthma: a reappraisal". European respiratory journal.2007; 29 (1): 179-84
4- Lemanske RF, Busse WW" Asthma: clinical expression and molecular mechanisms". J. Allergy Clin. Immunol.2010;125 S95-102.
5- Yawn BP. "Factors accounting for asthma variability: achieving optimal symptom control for individual patients" Respiratory Journal.2008; 17 (3): 138-147.
6- Kumar, Vinay; Abbas, Abul K; Fausto, Nelson et al., eds.. Robbins and Cotran pathologic basis of disease. (8thed.).Saunders.2010;p.688. 7- Moore WC, Pascual RM. "Update in asthma 2009". American Journal of Respiratory and Critical Care Medicine.2010; (11): 1181-7.
8- Self, Timothy; Chrisman, Cary; Finch, Christopher) "22. Asthma ". In Mary Anne Koda- Kimble, Brian K.Alldredge, et al. Applied therapeutics: the clinical use of drugs (9th ed.). Philadelphia Lippincott Williams & Wilkins.2009, 230-69.
9- Schiffman, George (18 December 2009)."Chronic obstructive pulmonary disease. Medicine Net. Archived from the original on 28 August 2010.
10- Barnes, PJ "Asthma", In Fauci, Anthony S; Braunwald, E, Kasper, DL. Harrisons principles of Internal Medicine (17th ed.).New York:2008
11- Maitre H, Similowski T, Derenne JP. Physical examination of adult patient with respiratory diseases; inspection and palpation"European respiratory Journal 1995; (9):1584- 93.
12- Werner, HA. Status asthmatics in children: a Review. Chest. 2010 119 (6):1596-1607 .
13- Maddox L, Schwartz DA. "The pathophysiology of asthma"Annu.Rev.Med.2002;53:477-98.
14- Delacourt, C (June 2004). "Consequences bronchiquesde l'asthme none traite" [Bronchial changes in untreated asthma]. Archives de Pediatrie.2004 : 71-73.
15- Jenkins C, Costtello J, Hodge L. "Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice" BMJ.2004; 328(7437):434.
16- Lecture 14: Hypersensitivity "(http:/www-immune. Path. Cam. ac. U.K /immuno/part 1/lec 13/lec 13-97.html) Retrived 2008-09-18.
17- "Allergy and asthma disease management center: Ask the Expert" Retrived 2008-09-18.
18- Karpiniski C and Touger-Decker R. Antioxidants and asthma. Top Clin Nutr 2009; 23(3):259-267.
19- Standardization of spirometry 1994 update . American Thoracic Society. AM J Resp Crit Care Med 1995; 152:1107- 36.
20- Ripoll, Brain c. Leutholtz, Ignacio. Exercise and disease management. 2nd ed. Boca Raton: CRC press.2011;p.100.ISBN 978-1- 4398-2759-8.
21- Ronchetti F, Villa MP, Ronchetti R, Bonci E, Latini L, Pascone R, et al. ABO/Secretor genetic complex and susceptibility to asthma in childhood. Eur Respir J. 2001; 17(6):389-92.
22- Chen YL, Chen JC, Lin TM, et al. ABO/ Secretor genetic Complex is associated with the susceptibility of childhood of asthma in Taiwan. Clin Exp Allergy. 2005; 35(7):926-32.
23- Bijanzadeh M, Ramachandra NB, Mahesh PA, et al. Lack of association between asthma and ABO blood group. Lung. 2009; 187(6):389-92.
24- Lasmar LM, Camargos PA ,Ordones AB, et al. Prevalence of allergicrhinitis rhinitis and its impact on the use of emergency care services in a group of children and adolescents with moderate to severe persistent asthma. Journal pediatr (Rio J).2007; 83(6):555-61
25- Gomes R, Nascimento EF, Araujo FC .Por que os homens buscam menos os servicos de suade do que as mulheres ? As explicacoes de homens com baixa escolaridade e homens com ensino superior. Cad Saude Publication 2007; 23(3):565-74.
26- Kauffmann F, Frette C, Pham QT et al. Association of blood group- related antigens to FEV1, Wheezing, and asthma AM J Respir Crit Care ed.1996 ; 153(1):76-82.
27- Schenkel-Brunner H. Human blood groups: Chemical and biochemical basis of antigen specificity. Vien: Springer- Verlag; 2000.
28- Al Shamma Y, Al Zubaidy A, Al Turjoman S. association of bronchial asthma to ABO blood groups in Najaf Governorate. Kufa Med. Journal 2008.Vol. 11. No.1.
29- Al- Abdulla NO, Al Naama LM, Hassan MK. Antioxidant's status in asthmatic attack in children. J Pak Med Assoc.2010; 60:1023-7. [PubMed].
30- Kanazawa H, Kurihara N, Hirata K, Takeda T.The role of free Radicles in airway obstruction in asthmatic patients. Chest1991;100:1319- 22.
31-Woods RK, Walters EH, Raven JM, Wolfe R, Ireland PD, Thien FCK and Abramson MJ. Food and nutrient intakes and asthma risk inyoungadults. AM J of Clin Neut 2003; 87(3):414-421
32- Comhair SA, Erzurum SC. "Antioxidant responses to Oxidant mediated Lung diseases". Am J Physiol Lung Cell Mol Physiol. 2002; 283; L246- L55.